Member Info for B_Positive

Criminally undervalued stock this is my personal take for my own investment.

Grant dosh would send this over 2p and probably make it test 3p.

IPO was 8p, ATH 12p.

Long way up. Way too cheap here

Several exits coming this quarter, including some hefty IR cash :)

The GV cash has been part used to increase our % in the first Sure Valley fund.

Guess what sits in the first fund?

The first Sure Valley Ventures fund ("SVV1") has an equity shareholding in iR as a result of iR's acquisition of SVV1's portfolio company Landvault in July 2024, in a US$450 million all-share transaction. At the time of the acquisition, SVV1 had a 7% shareholding in Landvault. iR's publicly declared valuation at that time, following a US$350 million fund raising, was US$5.1 billion.

iR now $15.5b public value, which Nick says in that interview is very conservative.

Now when the iR cash comes in and remember Sure Valley is looking to exit some of it shortly, as per their RNS Mindflair will now gain a bigger % and thus £££.

Worth a listen again over the weekend so you can see where this is going very shortly. :)

Q&A with Mindflair Director, Nick Lee

https://youtu.be/epFZ38U-KFs

I'll be taking advantage of sub 2p next week by adding before more exits, IR exit, updated NAV taking this to over 3p all come in.

Many exits coming

Big new board appointment.

A lot to come this way

Https://x.com/USCorpFilings/status/1940889578489237776

Boom

SEC Filings Digest

@USCorpFilings

Automated

$ Asset Acquisitions:

On July 2, 2025, Newbury Street Acquisition Corp and Infinite Reality, Inc. reached a settlement where Infinite Reality agreed to pay $5.25 million to Newbury Street in installments by September 18, 2025, resolving a previous dispute over a termination fee.

There's no need to be so upset

Nope, all from the RNS.

Dr Dan Gooding, Executive Director, Nuformix, said: "We are delighted to receive confirmation that Orphan Drug Designation has been granted for our NXP002 programme in IPF. The EMA award recognises NXP002's potential to significantly advance IPF treatment, thanks to its ability to modulate key targets in IPF progression, but also given its potential enhancement of current standard of care therapies. Orphan Drug Designation should significantly support our goal of progressing NXP002 through partnering and further development activities and, ultimately bringing solutions for fibrotic ILD indications to patients. We're thrilled that like us, the EMA has recognised the promise of this potential breakthrough medicine. We will now submit an application for US FDA orphan drug designation and continue discussions with potential future licensing partners and will provide further updates in due course as appropriate."

We await FDA submission and pharma partnership

Either sends this to the moon

Let's get this to 2p today just so we can see the back of Kat and then he can weep when it heads to 5p

GOODBYE KAT DAY

A friend of mine just bought 1mil shares.

Expect it to pop up delayed

One would suspect then FDA submission is close. Next week?

We will now submit an application for US FDA orphan drug designation and continue discussions with potential future licensing partners and will provide further updates in due course as appropriate."

Who fancy's some big news to drop next week.

FDA or Pharma deal and it goes to 1p.

Was stated as coming in due course a month ago.

Dr Dan Gooding, Executive Director, Nuformix, said: "We are delighted to receive confirmation that Orphan Drug Designation has been granted for our NXP002 programme in IPF. The EMA award recognises NXP002's potential to significantly advance IPF treatment, thanks to its ability to modulate key targets in IPF progression, but also given its potential enhancement of current standard of care therapies. Orphan Drug Designation should significantly support our goal of progressing NXP002 through partnering and further development activities and, ultimately bringing solutions for fibrotic ILD indications to patients. We're thrilled that like us, the EMA has recognised the promise of this potential breakthrough medicine. We will now submit an application for US FDA orphan drug designation and continue discussions with potential future licensing partners and will provide further updates in due course as appropriate."

Wow this is a crazy discovery.

Hope to load a chunk as this will shift hard from here and with gold news due too

Poor Raven, if knew how to play the game he could have averaged down at the low points and got out of this share he despises so much with a nice bit of profit.

But alas, he doesn't know how to play the game and is losing :(

Some announcements next week mush

Adoption of Bitcoin Treasury Policy

GSTechnologies Limited (LSE: GST), the fintech company, is pleased to announce the Company has formally adopted a Bitcoin treasury reserve policy (the "Treasury Policy"). The Treasury Policy allows for a significant proportion of the cash resources of the Company, as determined by the GST directors from time to time, to be held in Bitcoin. The GST Directors believe Bitcoin offers liquidity comparable to cash while serving as a reliable store of value.

The adoption of the Treasury Policy reflects the GST Directors' confidence in Bitcoin's ability to reduce counterparty and exchange rate risk, while potentially enhancing shareholder value beyond the Group's core operations. The Treasury Policy also aligns seamlessly with the Company's GS Money strategy and its operation of the Bake Cryptocurrency Platform, acquired in early 2025. As a fintech company specialising in digital asset services, GST is well-positioned to integrate Bitcoin into its corporate treasury, strengthening its competitive edge in the rapidly evolving blockchain economy.

Tone Goh, Chairman of GST, commented: "We continue to make significant progress with the Group's GS Money strategy, including the advancement of the Bake Cryptocurrency Platform acquired at the beginning of the year. Holding a significant proportion of the Company's cash resources in Bitcoin makes perfect sense given the Group's operations and the services it is providing to its clients. We are excited about the potential for Bitcoin to enhance shareholder value while reinforcing our leadership in the digital asset space."

Big day ahead here

GST is a 10-20p share

Totally not

at 10p the cap is way less than SWC